4.8 Letter

A TMPRSS2-ERG gene signature predicts prognosis of patients with prostate adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

Article Multidisciplinary Sciences

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Naiyer A. Rizvi et al.

SCIENCE (2015)

Review Oncology

Immune infiltration and prostate cancer

Amy Strasner et al.

FRONTIERS IN ONCOLOGY (2015)

Article Endocrinology & Metabolism

Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element

Liesbeth Clinckemalie et al.

MOLECULAR ENDOCRINOLOGY (2013)

Article Biochemistry & Molecular Biology

TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

F. Demichelis et al.

ONCOGENE (2007)

Article Urology & Nephrology

Prognostic value of the Gleason score in prostate cancer

L Egevad et al.

BJU INTERNATIONAL (2002)